S&P 500   4,220.82 (+0.98%)
DOW   33,126.20 (+0.66%)
QQQ   351.14 (+0.91%)
AAPL   179.85 (+1.47%)
MSFT   330.68 (+0.70%)
META   270.24 (+2.09%)
GOOGL   123.13 (+0.21%)
AMZN   122.49 (+1.58%)
TSLA   204.73 (+0.39%)
NVDA   394.60 (+4.30%)
NIO   7.47 (-0.80%)
BABA   82.85 (+4.15%)
AMD   119.70 (+1.26%)
T   15.81 (+0.51%)
F   12.06 (+0.50%)
MU   69.12 (+1.35%)
CGC   0.84 (+0.63%)
GE   104.65 (+3.07%)
DIS   88.52 (+0.64%)
AMC   4.61 (+2.44%)
PFE   38.06 (+0.11%)
PYPL   63.00 (+1.63%)
NFLX   402.16 (+1.75%)
S&P 500   4,220.82 (+0.98%)
DOW   33,126.20 (+0.66%)
QQQ   351.14 (+0.91%)
AAPL   179.85 (+1.47%)
MSFT   330.68 (+0.70%)
META   270.24 (+2.09%)
GOOGL   123.13 (+0.21%)
AMZN   122.49 (+1.58%)
TSLA   204.73 (+0.39%)
NVDA   394.60 (+4.30%)
NIO   7.47 (-0.80%)
BABA   82.85 (+4.15%)
AMD   119.70 (+1.26%)
T   15.81 (+0.51%)
F   12.06 (+0.50%)
MU   69.12 (+1.35%)
CGC   0.84 (+0.63%)
GE   104.65 (+3.07%)
DIS   88.52 (+0.64%)
AMC   4.61 (+2.44%)
PFE   38.06 (+0.11%)
PYPL   63.00 (+1.63%)
NFLX   402.16 (+1.75%)
S&P 500   4,220.82 (+0.98%)
DOW   33,126.20 (+0.66%)
QQQ   351.14 (+0.91%)
AAPL   179.85 (+1.47%)
MSFT   330.68 (+0.70%)
META   270.24 (+2.09%)
GOOGL   123.13 (+0.21%)
AMZN   122.49 (+1.58%)
TSLA   204.73 (+0.39%)
NVDA   394.60 (+4.30%)
NIO   7.47 (-0.80%)
BABA   82.85 (+4.15%)
AMD   119.70 (+1.26%)
T   15.81 (+0.51%)
F   12.06 (+0.50%)
MU   69.12 (+1.35%)
CGC   0.84 (+0.63%)
GE   104.65 (+3.07%)
DIS   88.52 (+0.64%)
AMC   4.61 (+2.44%)
PFE   38.06 (+0.11%)
PYPL   63.00 (+1.63%)
NFLX   402.16 (+1.75%)
S&P 500   4,220.82 (+0.98%)
DOW   33,126.20 (+0.66%)
QQQ   351.14 (+0.91%)
AAPL   179.85 (+1.47%)
MSFT   330.68 (+0.70%)
META   270.24 (+2.09%)
GOOGL   123.13 (+0.21%)
AMZN   122.49 (+1.58%)
TSLA   204.73 (+0.39%)
NVDA   394.60 (+4.30%)
NIO   7.47 (-0.80%)
BABA   82.85 (+4.15%)
AMD   119.70 (+1.26%)
T   15.81 (+0.51%)
F   12.06 (+0.50%)
MU   69.12 (+1.35%)
CGC   0.84 (+0.63%)
GE   104.65 (+3.07%)
DIS   88.52 (+0.64%)
AMC   4.61 (+2.44%)
PFE   38.06 (+0.11%)
PYPL   63.00 (+1.63%)
NFLX   402.16 (+1.75%)
NYSE:CHE

Chemed (CHE) Stock Forecast, Price & News

$534.72
+0.95 (+0.18%)
(As of 12:03 PM ET)
Compare
Today's Range
$530.05
$536.31
50-Day Range
$511.77
$567.21
52-Week Range
$430.16
$570.17
Volume
17,393 shs
Average Volume
69,183 shs
Market Capitalization
$8.03 billion
P/E Ratio
33.65
Dividend Yield
0.28%
Price Target
$610.00

Chemed MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
14.0% Upside
$610.00 Price Target
Short Interest
Bearish
3.24% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-0.33
Upright™ Environmental Score
News Sentiment
-0.47mentions of Chemed in the last 14 days
Based on 3 Articles This Week
Insider Trading
Selling Shares
$7.04 M Sold Last Quarter
Proj. Earnings Growth
11.36%
From $20.34 to $22.65 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.66 out of 5 stars

Medical Sector

167th out of 1,980 stocks

Home Health Care Services Industry

9th out of 14 stocks


CHE stock logo

About Chemed (NYSE:CHE) Stock

Chemed Corp. engages in the provision of healthcare and maintenance services. It operates through the VITAS and Roto-Rooter segments. The VITAS segment offers hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers. The Roto-Rooter segment includes plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers. The company was founded in 1970 and is headquartered in Cincinnati, OH.

Receive CHE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chemed and its competitors with MarketBeat's FREE daily newsletter.

CHE Stock News Headlines

Chemed Co. (CHE) To Go Ex-Dividend on May 24th
Chemed (NYSE:CHE) Now Covered by StockNews.com
Graphite Shortage Could Derail the $7 Trillion EV Transition
Graphite (not lithium) is expected to see the largest increase in demand of all battery metals over the next decade. But projections warn of an 8 million ton shortfall of graphite by 2040. That's why 97 more graphite mines are needed just to keep up with battery production for the $7 trillion transition to electric vehicles.
Chemed (CHE) Declares $0.38 Dividend
Chemed declares $0.38 dividend
3 Quality Stocks Ready to Soar
AI is Unstoppable. Now Is The Time!
AI, or Artificial Intelligence, is all the rage right now. AI technologies are empowering users in every industry to increase sales, efficiency, and productivity. It's truly a case of adapt or fail.
Chemed Co. (NYSE:CHE) CEO Sells $2,197,360.00 in Stock
Chemed (NYSE:CHE) Price Target Raised to $610.00
Baxter (BAX) Beats on Q1 Earnings, Ups '23 EPS View
Chemed Reports First-Quarter 2023 Results
EHC vs. CHE: Which Stock Is the Better Value Option?
Chemed Co. (NYSE:CHE) CEO Kevin J. Mcnamara Sells 3,000 Shares
See More Headlines

CHE Price History

CHE Company Calendar

Last Earnings
2/24/2023
Ex-Dividend for 3/17 Dividend
2/24/2023
Dividend Payable
3/17/2023
Ex-Dividend for 6/14 Dividend
5/24/2023
Today
6/01/2023
Dividend Payable
6/14/2023
Next Earnings (Estimated)
7/26/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Home health care services
Sub-Industry
Health Care Services
Sector
Medical
CUSIP
16359R10
Employees
14,167
Year Founded
1970

Price Target and Rating

Average Stock Price Forecast
$610.00
High Stock Price Forecast
$610.00
Low Stock Price Forecast
$610.00
Forecasted Upside/Downside
+14.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$249.62 million
Pretax Margin
14.60%

Debt

Sales & Book Value

Annual Sales
$2.13 billion
Cash Flow
$24.31 per share
Book Value
$58.59 per share

Miscellaneous

Free Float
14,415,000
Market Cap
$8.04 billion
Optionable
Optionable
Beta
0.54

Social Links


Key Executives

  • Kevin J. McNamaraKevin J. McNamara
    President, Chief Executive Officer & Director
  • David Patrick WilliamsDavid Patrick Williams
    Chief Financial Officer & Executive Vice President
  • Spencer S. LeeSpencer S. Lee
    Executive Vice President
  • Nicholas M. WestfallNicholas M. Westfall
    Executive Vice President
  • Thomas C. Hutton
    Director & Vice President













CHE Stock - Frequently Asked Questions

Should I buy or sell Chemed stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Chemed in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" CHE shares.
View CHE analyst ratings
or view top-rated stocks.

What is Chemed's stock price forecast for 2023?

1 brokerages have issued 12 month price targets for Chemed's shares. Their CHE share price forecasts range from $610.00 to $610.00. On average, they predict the company's share price to reach $610.00 in the next twelve months. This suggests a possible upside of 14.0% from the stock's current price.
View analysts price targets for CHE
or view top-rated stocks among Wall Street analysts.

How have CHE shares performed in 2023?

Chemed's stock was trading at $510.43 at the beginning of 2023. Since then, CHE stock has increased by 4.8% and is now trading at $535.12.
View the best growth stocks for 2023 here
.

Are investors shorting Chemed?

Chemed saw a increase in short interest in May. As of May 15th, there was short interest totaling 474,700 shares, an increase of 21.9% from the April 30th total of 389,300 shares. Based on an average daily volume of 68,000 shares, the short-interest ratio is presently 7.0 days. Approximately 3.2% of the company's shares are short sold.
View Chemed's Short Interest
.

When is Chemed's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, July 26th 2023.
View our CHE earnings forecast
.

How were Chemed's earnings last quarter?

Chemed Co. (NYSE:CHE) posted its quarterly earnings data on Friday, February, 24th. The company reported $5.39 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.30 by $0.09. The firm earned $546.65 million during the quarter, compared to analysts' expectations of $546.60 million. Chemed had a net margin of 11.07% and a trailing twelve-month return on equity of 37.83%. The company's revenue for the quarter was up 1.0% on a year-over-year basis. During the same period last year, the company earned $5.25 earnings per share.

How often does Chemed pay dividends? What is the dividend yield for Chemed?

Chemed announced a quarterly dividend on Monday, May 15th. Shareholders of record on Thursday, May 25th will be paid a dividend of $0.38 per share on Wednesday, June 14th. This represents a $1.52 dividend on an annualized basis and a yield of 0.28%. The ex-dividend date is Wednesday, May 24th.
Read our dividend analysis for CHE
.

Is Chemed a good dividend stock?

Chemed (NYSE:CHE) pays an annual dividend of $1.52 per share and currently has a dividend yield of 0.29%. The company has been increasing its dividend for 14 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 9.57%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CHE will have a dividend payout ratio of 6.71% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CHE.

What is Kevin J. McNamara's approval rating as Chemed's CEO?

1 employees have rated Chemed Chief Executive Officer Kevin J. McNamara on Glassdoor.com. Kevin J. McNamara has an approval rating of 100% among the company's employees. This puts Kevin J. McNamara in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Chemed own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemed investors own include AT&T (T), Home Depot (HD), Johnson & Johnson (JNJ), AbbVie (ABBV), Abbott Laboratories (ABT), CVS Health (CVS), Boeing (BA), UnitedHealth Group (UNH), Verizon Communications (VZ) and Chevron (CVX).

What is Chemed's stock symbol?

Chemed trades on the New York Stock Exchange (NYSE) under the ticker symbol "CHE."

Who are Chemed's major shareholders?

Chemed's stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (9.28%), William Blair Investment Management LLC (3.73%), Neuberger Berman Group LLC (3.55%), Kayne Anderson Rudnick Investment Management LLC (3.40%), Envestnet Asset Management Inc. (3.18%) and State Street Corp (2.95%). Insiders that own company stock include David Patrick Williams, Donald E Saunders, Kevin J Mcnamara, Michael D Witzeman, Nicholas Michael Westfall, Patrick P Grace, Spencer S Lee and Thomas P Rice.
View institutional ownership trends
.

How do I buy shares of Chemed?

Shares of CHE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Chemed's stock price today?

One share of CHE stock can currently be purchased for approximately $535.12.

How much money does Chemed make?

Chemed (NYSE:CHE) has a market capitalization of $8.04 billion and generates $2.13 billion in revenue each year. The company earns $249.62 million in net income (profit) each year or $15.89 on an earnings per share basis.

How many employees does Chemed have?

The company employs 14,167 workers across the globe.

How can I contact Chemed?

Chemed's mailing address is 255 EAST FIFTH STREET SUITE 2600, CINCINNATI OH, 45202. The official website for the company is www.chemed.com. The company can be reached via phone at (513) 762-6690 or via fax at 513-762-6590.

This page (NYSE:CHE) was last updated on 6/1/2023 by MarketBeat.com Staff

My Account -